Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells

Blood

Volumn 93, Issue 2, 1999, Pages 617-623

  Dürkop, Horst ^a,b   Foss, Hans Dieter ^a   Demel, Gudrun ^a   Klotzbach, Heike ^a   Hahn, Corinna ^a   Stein, Harald ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Department of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CD40 ANTIGEN; LATENT MEMBRANE PROTEIN 1; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; UNCLASSIFIED DRUG;

ACCESSORY CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE OVEREXPRESSION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MACROPHAGE; PRIORITY JOURNAL; REED STERNBERG CELL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0038767694     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.2.617.402k14_617_623     Document Type: Article

References (38)

1. Rothe M, Wong SC, Henzel WJ, Goeddel DV: A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681, 1994
2. Hu HM, O'Rourke K, Boguski MS, Dixit VM: A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 269:30069, 1994
3. Cheng G, Cleary AM, Ye Z, Hong DI, Lederman S, Baltimore D: Involvement of CRAF1, a relative of TRAF, in CD40 signalling. Science 267:1494, 1995
4. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389, 1995
5. Rothe M, Sarma V, Dixit VM, Goeddel DV: TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424, 1995
6. Sato T, Irie S, Reed JC: A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett 358:113, 1995
7. Ishida T, Tojo T, Aoki T, Kobayashi N, Ohishi T, Watanabe T, Yamamoto T, Inoue J: TRAF5, a novel tumor necrosis factor receptor-associated family protein, mediates CD40 signaling. Proc Natl Acad Sci USA 93:9437, 1996
8. Nakano H, Oshima H, Chung W, Williams-Abbott L, Ware CF, Yagita H, Okumura K: TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-b receptor. J Biol Chem 271: 14661, 1996
9. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959, 1994
10. Ishida T, Mizushima S, Azuma S, Kobayashi N, Tojo T, Suzuki K, Aizawa S, Watanabe T, Mosialos G, Kieff E, Yamamoto, Inoue J: Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signalling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem 271:28745, 1996
11. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795, 1995
12. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein,interacts with the death domain of Fas and initiates apoptosis. Cell 81:505, 1995
13. Stanger BZ, Leder P, Lee TH, Kim E, Seed B: RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:523, 1995
14. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495, 1995
15. Lotz M, Setareh M, von Kempis J, Schwarz H: The nerve growth factor/tumor necrosis factor receptor family. J Leukoc Biol 60:1, 1996
16. Baker SJ, Reddy P: Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1, 1996
17. Régnier CH, Tomasetto C, Moog-Lutz C, Chenard M-P, Wendung C, Basset P, Rio M-C: presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J Biol Chem 270:25715, 1995
18. Speiser DE, Lee SY, Wong B, Arron J, Santana A, Kong YY, Ohashi PS, Choi Y: A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J Exp Med 185:1777, 1997
19. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink HK, Pileri SA, Piris M, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
20. Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FGJ, Karpas A: A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor β-chain gene. Blood 72:234, 1988
21. Jat P, Arrand JR: In vitro transcription of two Epstein-Barr virus specified small RNA molecules. Nucleic Acids Res 10:3407, 1982
22. Milani S, Herbst H, Schuppan D, Hahn EG, Stein H: In situ hybridization for collagen types I, III, and IV mRNA in normal and fibrotic rat liver: Evidence for predominant expression in non-parenchymal liver cells. Hepatology 10:84, 1989
23. Herbst H, Steinbrecher E, Niedobitek G, Young LS, Brooks L, Müller-Lantzsch N, Stein H: Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 80:484, 1992
24. Cordell J, Falini B, Erber ON, Gosh AK, Abdulazir Z, Macdonald S, Pulford KA, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
25. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
26. Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G: Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-κB activation. Mol Cell Biol 16:7098, 1996
27. Liebowitz D: Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 338:1413, 1998
28. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dörken B: Constitutive nuclear factor-kB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100:2961, 1997
29. Lam KP, Kühn R, Rajewsky K: In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90:1073, 1997
30. Küppers R, Rajewsky K, Zhao M, Simons G, Laumann R, Fischer R, Hansmann ML: Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 91:10962, 1994
31. Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H: Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med 333:901, 1995
32. Ruprai AK, Pringle JH, Angel CA, Kind CN, Lauder I: Localization of immunoglobulin light chain mRNA expression in Hodgkin's disease by in situ hybridization. J Pathol 164:37, 1991
33. Lee SY, Park CG, Choi Y: T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med 183:669, 1996
34. O'Grady JT, Stewart S, Lowrey J, Howie SEM, Krajewski AS: CD40 expression in Hodgkin's disease. Am J Pathol 144:21, 1994
35. Carbone A, Gloghini A, Gattei V, Aldinucci D, Degan M, DePaoli P, Zagonel V, Pinto A: Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 85:780, 1995
36. Schwarting R, Gerdes J, Dürkop H, Falini B, Pileri S, Stein H: BER-H2: A new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitop. Blood 74:1678, 1989
37. Messineo C, Jamerson MH, Hunter E, Braziel R, Bagg A, Irving SG, Cossman J: Gene expression by single Reed-Sternberg cells: Pathways of apoptosis and activation. Blood 91:2443, 1998
38. Trümper L, Brady G, Bagg A, Gray D, Loke S, Greisser H, Wagman R, Braziel R, Gascoyne R, Vicini S, Iscove N, Cossman J, Mak T: Single-cell analysis of Hodgkin and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations. Blood 81:3097, 1993